Differences in Quality of Life between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients with Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

John M. Burke, Richard H.C. Van Der Jagt, Brad S. Kahl, Peter Wood, Tim E. Hawkins, David Macdonald, Mark Hertzberg, David Simpson, Michael Craig, Kathryn Kolibaba, Samar Issa, Mihaela Munteanu, Timothy W. Victor, Ian W. Flinn

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Differences in Quality of Life between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients with Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science